Group Manager - Microscopy
Role at ANSTO
Showing 221 - 240 of 395 results
ANSTO fights cancer
Commitment to undertake health research.
Research may lead to more effective anti-tumour drug
High intensity X-ray beam provides insights into the activity of natural killer cells.
Team Leader, NBI2 Data Acquisition
Role at ANSTO
Synchrotron techniques provide insights into swifter battery charging
New research published in the journal Nature Nanotechnology shows that the next generation of lithium-sulphur (Li||S) batteries may be capable of being charged in less than five minutes, instead of several hours as is currently the case.
Innovator in energy and sustainability uses power of synchrotron light to make advances
Beamline Scientist – Advanced Diffraction & Scattering
Role at ANSTO
First malaria-human contact mapped with Nobel Prize-winning technology
Research represents significant step towards developing vaccine
ANSTO User Meeting 2021 - Topics
Principal Scientist - Soft x-ray spectroscopy
Role at ANSTO
AMSI Board welcomes Prof Andrew Peele
Director of the Australian Synchrotron Prof Andrew Peele has been appointed to Australian Mathematical Sciences Board.
Research that matters
Sydney
Group Executive Nuclear Science and Technology
Andrew Peele was appointed Group Executive for ANSTO Nuclear Science and Technology in July 2021 and was Director of the Australian Synchrotron from 2013 -2021. He is an adjunct Professor of Physics at La Trobe University.
Giving waste plastics a second life as high-performance materials
A new study has shown that, rather than being discarded, plastics can be transformed into valuable carbon nanomaterials that help solve both energy and environmental challenges.
Australian Synchrotron to officially become part of the nuclear family
Australia’s nuclear science capabilities have been central to our fight against COVID-19
ANSTO scientists share approach on the global stage at the IAEA General Conference.
New grant introduces state-of-the-art capability in stress engineering for Australian industry
New facility will greatly enhance Australia’s capability in stress engineering for industry
New antibody-like molecule which could be used in therapy to prevent infection from multiple forms of malaria
The protein mapping workhorses of the Australian Synchrotron, Macromolecular and Microfocus crystallography beamlines, MX1 and 2, continue to support important biomedical research in the development of vaccines and new therapeutics.
New experts join Australia's nuclear agency: Focus on innovation, users delivering more benefits to Australians
Senior Scientist - XAS
Career Statement and Role at ANSTO